« Return to News | CROs/Service Providers

ICON partners with Boston Clinical Research Institute

Friday, May 13, 2011 11:25 AM

Global CRO ICON, based in Ireland, is widening its access to key opinion leader expertise and clinical investigators, both in the U.S. and worldwide, through an alliance with Boston Clinical Research Institute (BCRI), according to PharmaTimes.

BCRI is an Academic Research Organization (ARO) based in Boston, Mass. The strategic alliance will leverage BCRI’s leadership in clinical strategy, study planning and academic relationships by combining it with ICON’s experience in executing global clinical trials, the company said.

“We believe that the future of clinical research is collaboration between the ARO and the CRO,” said Dr. Michael Gibson, BCRI founder and senior consultant. “ICON clearly recognizes the incremental benefits of collaboration with the thought leaders in the medical community to optimize study planning, execution and credibility.”

ICON said BCRI provides scientific consultancy in study design, using expert practicing clinicians and key opinion leaders from premier medical institutions, as well as academic leadership for steering committees, advisory panel participation, endpoint committees, core laboratory services and data safety and monitoring boards.

The Institute also maintains a network of global investigators in all medical specialties and sub-specialties. ICON CEO Peter Gray said these activities will give ICON and its clients access to “a breadth of expertise in the key opinion leader community and to investigators worldwide, including national and international leaders.”


Among the benefits ICON expects to reap from the new relationship are enhanced study planning, design, site selection and enrollment performance.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.